197 related articles for article (PubMed ID: 25036192)
1. A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR.
White H; Deprez L; Corbisier P; Hall V; Lin F; Mazoua S; Trapmann S; Aggerholm A; Andrikovics H; Akiki S; Barbany G; Boeckx N; Bench A; Catherwood M; Cayuela JM; Chudleigh S; Clench T; Colomer D; Daraio F; Dulucq S; Farrugia J; Fletcher L; Foroni L; Ganderton R; Gerrard G; Gineikienė E; Hayette S; El Housni H; Izzo B; Jansson M; Johnels P; Jurcek T; Kairisto V; Kizilors A; Kim DW; Lange T; Lion T; Polakova KM; Martinelli G; McCarron S; Merle PA; Milner B; Mitterbauer-Hohendanner G; Nagar M; Nickless G; Nomdedéu J; Nymoen DA; Leibundgut EO; Ozbek U; Pajič T; Pfeifer H; Preudhomme C; Raudsepp K; Romeo G; Sacha T; Talmaci R; Touloumenidou T; Van der Velden VH; Waits P; Wang L; Wilkinson E; Wilson G; Wren D; Zadro R; Ziermann J; Zoi K; Müller MC; Hochhaus A; Schimmel H; Cross NC; Emons H
Leukemia; 2015 Feb; 29(2):369-76. PubMed ID: 25036192
[TBL] [Abstract][Full Text] [Related]
2. A review of the challenge in measuring and standardizing BCR-ABL1.
Yu S; Cui M; He X; Jing R; Wang H
Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
[TBL] [Abstract][Full Text] [Related]
3. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.
Cross NC; White HE; Ernst T; Welden L; Dietz C; Saglio G; Mahon FX; Wong CC; Zheng D; Wong S; Wang SS; Akiki S; Albano F; Andrikovics H; Anwar J; Balatzenko G; Bendit I; Beveridge J; Boeckx N; Cerveira N; Cheng SM; Colomer D; Czurda S; Daraio F; Dulucq S; Eggen L; El Housni H; Gerrard G; Gniot M; Izzo B; Jacquin D; Janssen JJ; Jeromin S; Jurcek T; Kim DW; Machova-Polakova K; Martinez-Lopez J; McBean M; Mesanovic S; Mitterbauer-Hohendanner G; Mobtaker H; Mozziconacci MJ; Pajič T; Pallisgaard N; Panagiotidis P; Press RD; Qin YZ; Radich J; Sacha T; Touloumenidou T; Waits P; Wilkinson E; Zadro R; Müller MC; Hochhaus A; Branford S
Leukemia; 2016 Sep; 30(9):1844-52. PubMed ID: 27109508
[TBL] [Abstract][Full Text] [Related]
5. Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.
Furuya D; Moriai M; Koizumi Y; Endo T; Asanuma K; Yanagihara N; Takahashi S
Int J Clin Oncol; 2019 Jul; 24(7):871-875. PubMed ID: 30798394
[TBL] [Abstract][Full Text] [Related]
6. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.
Cross NC; Hochhaus A; Müller MC
Ann Hematol; 2015 Apr; 94 Suppl 2():S219-25. PubMed ID: 25814088
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 transcript types showed distinct laboratory characteristics in patients with chronic myeloid leukemia.
Vasconcelos AP; Azevedo IF; Melo FCBC; Neves WB; Azevedo ACAC; Melo RAM
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28437552
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of armored RNA-based standards for quantification of BCR-ABL1
Fu Y; Zhang R; Wu Q; Zhang J; Bao L; Li J
J Clin Lab Anal; 2018 Nov; 32(9):e22612. PubMed ID: 29959790
[TBL] [Abstract][Full Text] [Related]
9. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
[TBL] [Abstract][Full Text] [Related]
10. Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA.
Brown JT; Beldorth IJ; Laosinchai-Wolf W; Fahey ME; Jefferson KL; Ruskin AK; Roth JJ; Cai L; Watt CD; Press RD; Yang F; Hedges JB; Andruss BF
J Mol Diagn; 2019 Jul; 21(4):718-733. PubMed ID: 31026597
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of suitable housekeeping genes for gene expression studies in BCR-ABL1 positive B-lineage acute lymphoblastic leukemia.
Gupta DG; Varma N; Kumar A; Naseem S; Sachdeva MUS; Bose P; Binota J; Gupta M; Sonam P; Rana P; Malhotra P; Varma S
Mol Biol Rep; 2022 Jun; 49(6):4841-4848. PubMed ID: 35344115
[TBL] [Abstract][Full Text] [Related]
12. Standardization of BCR-ABL1 quantification on the international scale in China using locally developed secondary reference panels.
Zhang JW; Fu Y; Wu QS; Bao LH; Peng RX; Zhang R; Li JM
Exp Hematol; 2020 Jan; 81():42-49.e3. PubMed ID: 31863797
[TBL] [Abstract][Full Text] [Related]
13. Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.
Müller MC; Erben P; Saglio G; Gottardi E; Nyvold CG; Schenk T; Ernst T; Lauber S; Kruth J; Hehlmann R; Hochhaus A;
Leukemia; 2008 Jan; 22(1):96-102. PubMed ID: 17943168
[TBL] [Abstract][Full Text] [Related]
14. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Kjaer L; Skov V; Andersen MT; Aggerholm A; Clair P; Gniot M; Soeby K; Udby L; Dorff MH; Hasselbalch H; Pallisgaard N
Eur J Haematol; 2019 Jul; 103(1):26-34. PubMed ID: 30985947
[TBL] [Abstract][Full Text] [Related]
15. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.
Jennings LJ; George D; Czech J; Yu M; Joseph L
J Mol Diagn; 2014 Mar; 16(2):174-9. PubMed ID: 24389534
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia.
Franke GN; Maier J; Wildenberger K; Cross M; Giles FJ; Müller MC; Hochhaus A; Niederwieser D; Lange T
J Mol Diagn; 2020 Jan; 22(1):81-89. PubMed ID: 31669230
[TBL] [Abstract][Full Text] [Related]
18. Quality control methods for optimal BCR-ABL1 clinical testing in human whole blood samples.
Stanoszek LM; Crawford EL; Blomquist TM; Warns JA; Willey PF; Willey JC
J Mol Diagn; 2013 May; 15(3):391-400. PubMed ID: 23541592
[TBL] [Abstract][Full Text] [Related]
19.
Pagani IS; Dang P; Kommers IO; Goyne JM; Nicola M; Saunders VA; Braley J; White DL; Yeung DT; Branford S; Hughes TP; Ross DM
Haematologica; 2018 Dec; 103(12):2026-2032. PubMed ID: 29976745
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
